Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference
Authors' conclusion
The findings of this survey could be used in the development of an SDM tool that can potentially provide insights into patient preferences and is generally well received by patients and rheumatologists with good agreement and reliability.
Study context
- Population
- Patients with rheumatoid arthritis (RA) (and rheumatologists in qualitative interviews)quantitative survey
- Participants
- 944 patients
- Outcome
- Most important treatment attributes from patients' perspective (relative importance)
Methodological detailstwo phases: qualitative interviews and quantitative survey, adaptive conjoint exercise, Qualitative interviews: patients with RA (n = 10) and rheumatologists (n = 10)
- Two phases: qualitative interviews and quantitative survey
- Adaptive conjoint exercise
- Qualitative interviews: patients with RA (n = 10) and rheumatologists (n = 10)
Main finding
As reported in the abstract
Relative importance of treatment attributes
Route of administration and dosing frequency (most important)
38%
Serious side effects (second most important)
33%
Observational data: associations, not effects.
Further findings
Tool stability (recontact survey, relative importance of attributes)
- Tool stability (n = 124/172; recontact n = 172/944)
- 72%
Original publication
Development of an Interactive Tool to Support Shared Decision‐Making in Rheumatoid Arthritis: Treatment Attribute Preference. Arthritis Care Res (Hoboken). Published 13 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →